Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases

Pharmacology and Therapeutics

Volumn 143, Issue 2, 2014, Pages 168-180

  Eom, Gwang Hyeon ^a   Kook, Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Cardiovascular diseases; Histone deacetylase inhibitors; Histone deacetylases; Posttranslational modifications; Therapeutics

Indexed keywords

ABEXINOSTAT; ENTINOSTAT; GIVINOSTAT; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 10; HISTONE DEACETYLASE 11; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE INHIBITOR; MOCETINOSTAT; NONHISTONE PROTEIN; PANOBINOSTAT; RESMINOSTAT; ROMIDEPSIN; SB 939; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; UNCLASSIFIED DRUG; VORINOSTAT;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HOMEOSTASIS; HUMAN; HYPERTENSION; NEOINTIMA; NITROSYLATION; NONHUMAN; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN PROCESSING; SUMOYLATION; TRANSCRIPTION REGULATION; CHEMISTRY; HEART DISEASE; METABOLISM; VASCULAR DISEASE;

CARDIOVASCULAR DISEASES; HEART DISEASES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; VASCULAR DISEASES;

EID: 84902549379     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.02.012     Document Type: Review

References (157)

1. T. Ago, T. Liu, P. Zhai, W. Chen, H. Li, and J.D. Molkentin et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy Cell 133 2008 978 993
2. T. Azechi, D. Kanehira, T. Kobayashi, R. Sudo, A. Nishimura, and F. Sato et al. Trichostatin A, an HDAC class I/II inhibitor, promotes pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase J Atheroscler Thromb 20 2013 538 547
3. A. Barski, S. Cuddapah, K. Cui, T.Y. Roh, D.E. Schones, and Z. Wang et al. High-resolution profiling of histone methylations in the human genome Cell 129 2007 823 837
4. A.A. Beg, T.S. Finco, P.V. Nantermet, and A.S. Baldwin Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation Mol Cell Biol 13 1993 3301 3310
5. B.C. Bernardo, K.L. Weeks, L. Pretorius, and J.R. McMullen Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies Pharmacol Ther 128 2010 191 227
6. G. Blander, and L. Guarente The Sir2 family of protein deacetylases Annu Rev Biochem 73 2004 417 435
7. H.J. Bogaard, S. Mizuno, A.A. Hussaini, S. Toldo, A. Abbate, and D. Kraskauskas et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats Am J Respir Crit Care Med 183 2011 1402 1410
8. J. Bossuyt, K. Helmstadter, X. Wu, H. Clements-Jewery, R.S. Haworth, and M. Avkiran et al. Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure Circ Res 102 2008 695 702
9. A. Brandl, T. Wagner, K.M. Uhlig, S.K. Knauer, R.H. Stauber, and F. Melchior et al. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress J Mol Cell Biol 4 2012 284 293
10. E.W. Bush, and T.A. McKinsey Targeting histone deacetylases for heart failure Expert Opin Ther Targets 13 2009 767 784
11. M.A. Cavasin, K. Demos-Davies, T.R. Horn, L.A. Walker, D.D. Lemon, and N. Birdsey et al. Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism Circ Res 110 2012 739 748
12. C.W. Chang, L. Lee, D. Yu, K. Dao, J. Bossuyt, and D.M. Bers Acute beta-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays G(q)-induced transcriptional activation J Biol Chem 288 2013 192 204
13. S. Chang, T.A. McKinsey, C.L. Zhang, J.A. Richardson, J.A. Hill, and E.N. Olson Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development Mol Cell Biol 24 2004 8467 8476
14. L.F. Chen, Y. Mu, and W.C. Greene Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB EMBO J 21 2002 6539 6548
15. Y.K. Cho, G.H. Eom, H.J. Kee, H.S. Kim, W.Y. Choi, and K.I. Nam et al. Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats Circ J 74 2010 760 770
16. J.H. Choi, K.H. Nam, J. Kim, M.W. Baek, J.E. Park, and H.Y. Park et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice Arterioscler Thromb Vasc Biol 25 2005 2404 2409
17. C. Choudhary, C. Kumar, F. Gnad, M.L. Nielsen, M. Rehman, and T.C. Walther et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions Science 325 2009 834 840
18. C. Colussi, C. Mozzetta, A. Gurtner, B. Illi, J. Rosati, and S. Straino et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment Proc Natl Acad Sci U S A 105 2008 19183 19187
19. S. Corre, A. Primot, Y. Baron, J. Le Seyec, C. Goding, and M.D. Galibert Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation J Biol Chem 284 2009 18851 18862
20. M.P. Czubryt, J. McAnally, G.I. Fishman, and E.N. Olson Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5 Proc Natl Acad Sci U S A 100 2003 1711 1716
21. G. David, M.A. Neptune, and R.A. DePinho SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities J Biol Chem 277 2002 23658 23663
22. A.J. de Ruijter, A.H. van Gennip, H.N. Caron, S. Kemp, and A.B. van Kuilenburg Histone deacetylases (HDACs): characterization of the classical HDAC family Biochem J 370 2003 737 749
23. C.F. Deroanne, K. Bonjean, S. Servotte, L. Devy, A. Colige, and N. Clausse et al. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling Oncogene 21 2002 427 436
24. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
25. M. Duvic, and J. Vu Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma Expert Opin Investig Drugs 16 2007 1111 1120
26. G.H. Eom, Y.K. Cho, J.H. Ko, S. Shin, N. Choe, and Y. Kim et al. Casein kinase-2alpha1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart Circulation 123 2011 2392 2403
27. G.H. Eom, Y.S. Nam, J.G. Oh, N. Choe, H.K. Min, and E.K. Yoo et al. Regulation of Acetylation of Histone Deacetylase 2 by p300/CBP-Associated Factor/Histone Deacetylase 5 in the Development of Cardiac Hypertrophy Circ Res 114 2014 [Epub ahead of print]
28. P.M. Evans, W. Zhang, X. Chen, J. Yang, K.K. Bhakat, and C. Liu Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation J Biol Chem 282 2007 33994 34002
29. H.M. Findeisen, F. Gizard, Y. Zhao, H. Qing, E.B. Heywood, and K.L. Jones et al. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition Arterioscler Thromb Vasc Biol 31 2011 851 860
30. A.V. Finn, M. Nakano, J. Narula, F.D. Kolodgie, and R. Virmani Concept of vulnerable/unstable plaque Arterioscler Thromb Vasc Biol 30 2010 1282 1292
31. D.D. Fischer, R. Cai, U. Bhatia, F.A. Asselbergs, C. Song, and R. Terry et al. Isolation and characterization of a novel class II histone deacetylase, HDAC10 J Biol Chem 277 2002 6656 6666
32. W. Fischle, F. Dequiedt, M.J. Hendzel, M.G. Guenther, M.A. Lazar, and W. Voelter et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR Mol Cell 9 2002 45 57
33. J.E. Fish, C.C. Matouk, A. Rachlis, S. Lin, S.C. Tai, and C. D'Abreo et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code J Biol Chem 280 2005 24824 24838
34. E.J. Fitzgerald O'Connor, I.I. Badshah, L.Y. Addae, P. Kundasamy, S. Thanabalasingam, and D. Abioye et al. Histone deacetylase 2 is upregulated in normal and keloid scars J Invest Dermatol 132 2012 1293 1296
35. J.A. Fox, and A.E. Hugh Localization of atheroma: a theory based on boundary layer separation Br Heart J 28 1966 388 399
36. N. Frey, and E.N. Olson Cardiac hypertrophy: the good, the bad, and the ugly Annu Rev Physiol 65 2003 45 79
37. R. Furumai, A. Matsuyama, N. Kobashi, K.H. Lee, M. Nishiyama, and H. Nakajima et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases Cancer Res 62 2002 4916 4921
38. P. Gallo, M.V. Latronico, P. Gallo, S. Grimaldi, F. Borgia, and M. Todaro et al. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure Cardiovasc Res 80 2008 416 424
39. H. Geng, C.T. Harvey, J. Pittsenbarger, Q. Liu, T.M. Beer, and C. Xue et al. HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia J Biol Chem 286 2011 38095 38102
40. M.H. Glickman, and A. Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol Rev 82 2002 373 428
41. M.A. Glozak, N. Sengupta, X. Zhang, and E. Seto Acetylation and deacetylation of non-histone proteins Gene 363 2005 15 23
42. J.W. Gordon, C. Pagiatakis, J. Salma, M. Du, J.J. Andreucci, and J. Zhao et al. Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells J Biol Chem 284 2009 19027 19042
43. A. Granger, I. Abdullah, F. Huebner, A. Stout, T. Wang, and T. Huebner et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice FASEB J 22 2008 3549 3560
44. W. Gu, and R.G. Roeder Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 1997 595 606
45. B. Guillemette, P. Drogaris, H.H. Lin, H. Armstrong, K. Hiragami-Hamada, and A. Imhof et al. H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation PLoS Genet 7 2011 e1001354
46. W. Guo, B. Shan, R.C. Klingsberg, X. Qin, and J.A. Lasky Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition Am J Physiol Lung Cell Mol Physiol 297 2009 L864 L870
47. C.H. Ha, B.S. Jhun, H.Y. Kao, and Z.G. Jin VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis Arterioscler Thromb Vasc Biol 28 2008 1782 1788
48. C.H. Ha, J.Y. Kim, J. Zhao, W. Wang, B.S. Jhun, and C. Wong et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy Proc Natl Acad Sci U S A 107 2010 15467 15472
49. C.H. Ha, W. Wang, B.S. Jhun, C. Wong, A. Hausser, and K. Pfizenmaier et al. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis J Biol Chem 283 2008 14590 14599
50. M. Haberland, R.L. Montgomery, and E.N. Olson The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat Rev Genet 10 2009 32 42
51. M.A. Halili, M.R. Andrews, L.I. Labzin, K. Schroder, G. Matthias, and C. Cao et al. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS J Leukoc Biol 87 2010 1103 1114
52. I.F. Harrison, and D.T. Dexter Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Pharmacol Ther 140 2013 34 52
53. R.S. Haworth, K. Stathopoulou, A.J. Candasamy, and M. Avkiran Neurohormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms Circ Res 110 2012 1585 1595
54. J.A. Hill, and E.N. Olson Cardiac plasticity N Engl J Med 358 2008 1370 1380
55. S.R. Hubbard, and J.H. Till Protein tyrosine kinase structure and function Annu Rev Biochem 69 2000 373 398
56. C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito, and A. Nixon et al. HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455 458
57. D.J. Hunter, and K.S. Reddy Noncommunicable diseases N Engl J Med 369 2013 1336 1343
58. S. Ishibashi, M.S. Brown, J.L. Goldstein, R.D. Gerard, R.E. Hammer, and J. Herz Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery J Clin Invest 92 1993 883 893
59. F.A. Ismat, M. Zhang, H. Kook, B. Huang, R. Zhou, and V.A. Ferrari et al. Homeobox protein Hop functions in the adult cardiac conduction system Circ Res 96 2005 898 903
60. A. Ito, Y. Kawaguchi, C.H. Lai, J.J. Kovacs, Y. Higashimoto, and E. Appella et al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation EMBO J 21 2002 6236 6245
61. K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, and P.J. Barnes et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 203 2006 7 13
62. P. Jones, S. Altamura, P.K. Chakravarty, O. Cecchetti, R. De Francesco, and P. Gallinari et al. A series of novel, potent, and selective histone deacetylase inhibitors Bioorg Med Chem Lett 16 2006 5948 5952
63. P. Jones, S. Altamura, R. De Francesco, P. Gallinari, A. Lahm, and P. Neddermann et al. Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases Bioorg Med Chem Lett 18 2008 1814 1819
64. D. Kaluza, J. Kroll, S. Gesierich, Y. Manavski, J.N. Boeckel, and C. Doebele et al. Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells Arterioscler Thromb Vasc Biol 33 2013 533 543
65. D. Kaluza, J. Kroll, S. Gesierich, T.P. Yao, R.A. Boon, and E. Hergenreider et al. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin EMBO J 30 2011 4142 4156
66. H.Y. Kao, C.H. Lee, A. Komarov, C.C. Han, and R.M. Evans Isolation and characterization of mammalian HDAC10, a novel histone deacetylase J Biol Chem 277 2002 187 193
67. T. Kawamura, K. Ono, T. Morimoto, H. Wada, M. Hirai, and K. Hidaka et al. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes J Biol Chem 280 2005 19682 19688
68. H.J. Kee, G.H. Eom, H. Joung, S. Shin, J.R. Kim, and Y.K. Cho et al. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy Circ Res 103 2008 1259 1269
69. H.J. Kee, and H. Kook Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy J Mol Cell Cardiol 47 2009 770 780
70. H.J. Kee, J.S. Kwon, S. Shin, Y. Ahn, M.H. Jeong, and H. Kook Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4 Vascul Pharmacol 55 2011 127 134
71. H.J. Kee, I.S. Sohn, K.I. Nam, J.E. Park, Y.R. Qian, and Z. Yin et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding Circulation 113 2006 51 59
72. M.S. Kim, H.J. Kwon, Y.M. Lee, J.H. Baek, J.E. Jang, and S.W. Lee et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes Nat Med 7 2001 437 443
73. I.A. Kim, J.H. Shin, I.H. Kim, J.H. Kim, J.S. Kim, and H.G. Wu et al. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53 Clin Cancer Res 12 2006 940 949
74. O. Kirsh, J.S. Seeler, A. Pichler, A. Gast, S. Muller, and E. Miska et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase EMBO J 21 2002 2682 2691
75. C.M. Koch, R.M. Andrews, P. Flicek, S.C. Dillon, U. Karaoz, and G.K. Clelland et al. The landscape of histone modifications across 1% of the human genome in five human cell lines Genome Res 17 2007 691 707
76. D.M. Koepp, L.K. Schaefer, X. Ye, K. Keyomarsi, C. Chu, and J.W. Harper et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase Science 294 2001 173 177
77. X. Kong, M. Fang, P. Li, F. Fang, and Y. Xu HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells J Mol Cell Cardiol 46 2009 292 299
78. Y. Kong, P. Tannous, G. Lu, K. Berenji, B.A. Rothermel, and E.N. Olson et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy Circulation 113 2006 2579 2588
79. H. Kook, J.J. Lepore, A.D. Gitler, M.M. Lu, W. Wing-Man Yung, and J. Mackay et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop J Clin Invest 112 2003 863 871
80. H.A. Lee, D.Y. Lee, H.M. Cho, S.Y. Kim, Y. Iwasaki, and I.K. Kim Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension Circ Res 112 2013 1004 1012
81. T.M. Lee, M.S. Lin, and N.C. Chang Inhibition of histone deacetylase on ventricular remodeling in infarcted rats Am J Physiol Heart Circ Physiol 293 2007 H968 H977
82. L. Levy, Y. Wei, C. Labalette, Y. Wu, C.A. Renard, and M.A. Buendia et al. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction Mol Cell Biol 24 2004 3404 3414
83. M. Li, J. Luo, C.L. Brooks, and W. Gu Acetylation of p53 inhibits its ubiquitination by Mdm2 J Biol Chem 277 2002 50607 50611
84. D. Li, S. Xie, Y. Ren, L. Huo, J. Gao, and D. Cui et al. Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner Protein Cell 2 2011 150 160
85. H.K. Lin, L. Wang, Y.C. Hu, S. Altuwaijri, and C. Chang Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase EMBO J 21 2002 4037 4048
86. F. Liu, M.D. Levin, N.B. Petrenko, M.M. Lu, T. Wang, and L.J. Yuan et al. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin J Mol Cell Cardiol 45 2008 715 723
87. D. Malhotra, R.K. Thimmulappa, N. Mercado, K. Ito, P. Kombairaju, and S. Kumar et al. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients J Clin Invest 121 2011 4289 4302
88. A. Margariti, A. Zampetaki, Q. Xiao, B. Zhou, E. Karamariti, and D. Martin et al. Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin Circ Res 106 2010 1202 1211
89. P.A. Marks, V.M. Richon, R. Breslow, and R.A. Rifkind Histone deacetylase inhibitors as new cancer drugs Curr Opin Oncol 13 2001 477 483
90. M. Martin, M. Potente, V. Janssens, D. Vertommen, J.C. Twizere, and M.H. Rider et al. Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis Proc Natl Acad Sci U S A 105 2008 4727 4732
91. F.O. Martinez, A. Sica, A. Mantovani, and M. Locati Macrophage activation and polarization Front Biosci 13 2008 453 461
92. T. Marumo, K. Hishikawa, M. Yoshikawa, J. Hirahashi, S. Kawachi, and T. Fujita Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury Am J Physiol Renal Physiol 298 2010 F133 F141
93. S. Maudsley, K.L. Pierce, A.M. Zamah, W.E. Miller, S. Ahn, and Y. Daaka et al. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor J Biol Chem 275 2000 9572 9580
94. H.C. McGill Jr., C.A. McMahan, and S.S. Gidding Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study Circulation 117 2008 1216 1227
95. T.A. McKinsey, C.L. Zhang, J. Lu, and E.N. Olson Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation Nature 408 2000 106 111
96. T.A. McKinsey, C.L. Zhang, and E.N. Olson Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5 Proc Natl Acad Sci U S A 97 2000 14400 14405
97. F. Melchior SUMO - nonclassical ubiquitin Annu Rev Cell Dev Biol 16 2000 591 626
98. F. Meng, M. Han, B. Zheng, C. Wang, R. Zhang, and X.H. Zhang et al. All-trans retinoic acid increases KLF4 acetylation by inducing HDAC2 phosphorylation and its dissociation from KLF4 in vascular smooth muscle cells Biochem Biophys Res Commun 387 2009 13 18
99. S. Minucci, and P.G. Pelicci Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat Rev Cancer 6 2006 38 51
100. M. Miranda, and A. Sorkin Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms Mol Interv 7 2007 157 167
101. J.D. Molkentin, J.R. Lu, C.L. Antos, B. Markham, J. Richardson, and J. Robbins et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy Cell 93 1998 215 228
102. N. Monteforte, C. Napolitano, and S.G. Priori Genetics and arrhythmias: diagnostic and prognostic applications Rev Esp Cardiol 65 2012 278 286
103. R.L. Montgomery, C.A. Davis, M.J. Potthoff, M. Haberland, J. Fielitz, and X. Qi et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility Genes Dev 21 2007 1790 1802
104. D. Mottet, A. Bellahcene, S. Pirotte, D. Waltregny, C. Deroanne, and V. Lamour et al. Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis Circ Res 101 2007 1237 1246
105. S.E. Mullican, C.A. Gaddis, T. Alenghat, M.G. Nair, P.R. Giacomin, and L.J. Everett et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation Genes Dev 25 2011 2480 2488
106. C.E. Murry, M.H. Soonpaa, H. Reinecke, H. Nakajima, H.O. Nakajima, and M. Rubart et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 664 668
107. A. Nebbioso, F. Manzo, M. Miceli, M. Conte, L. Manente, and A. Baldi et al. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes EMBO Rep 10 2009 776 782
108. T. Niki, K. Rombouts, P. De Bleser, K. De Smet, V. Rogiers, and D. Schuppan et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture Hepatology 29 1999 858 867
109. H. Noh, E.Y. Oh, J.Y. Seo, M.R. Yu, Y.O. Kim, and H. Ha et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury Am J Physiol Renal Physiol 297 2009 F729 F739
110. A. Nott, P.M. Watson, J.D. Robinson, L. Crepaldi, and A. Riccio S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons Nature 455 2008 411 415
111. H. Okamoto, Y. Fujioka, A. Takahashi, T. Takahashi, T. Taniguchi, and Y. Ishikawa et al. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1) J Atheroscler Thromb 13 2006 183 191
112. E.J. Park, D.W. Chan, J.H. Park, M.A. Oettinger, and J. Kwon DNA-PK is activated by nucleosomes and phosphorylates H2AX within the nucleosomes in an acetylation-dependent manner Nucleic Acids Res 31 2003 6819 6827
113. M.K. Pflum, J.K. Tong, W.S. Lane, and S.L. Schreiber Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation J Biol Chem 276 2001 47733 47741
114. A. Ramjiawan, R.A. Bagchi, A. Blant, L. Albak, M.A. Cavasin, and T.R. Horn et al. Roles of histone deacetylation and AMP kinase in regulation of cardiomyocyte PGC-1alpha gene expression in hypoxia Am J Physiol Cell Physiol 304 2013 C1064 C1072
115. C.A. Risebro, L.K. Petchey, N. Smart, J. Gomes, J. Clark, and J.M. Vieira et al. Epistatic rescue of Nkx2.5 adult cardiac conduction disease phenotypes by prospero-related homeobox protein 1 and HDAC3 Circ Res 111 2012 e19 e31
116. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
117. L. Rossig, H. Li, B. Fisslthaler, C. Urbich, I. Fleming, and U. Forstermann et al. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis Circ Res 91 2002 837 844
118. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, and Y. Qin et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
119. H. Santos-Rosa, E. Valls, T. Kouzarides, and M. Martinez-Balbas Mechanisms of P/CAF auto-acetylation Nucleic Acids Res 31 2003 4285 4292
120. V. Sarrazy, F. Billet, L. Micallef, B. Coulomb, and A. Desmoulière Mechanisms of pathological scarring: role of myofibroblasts and current developments Wound Repair Regen 19 2011 S10 S15
121. M. Serrano, G.J. Hannon, and D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707
122. M.R. Shakespear, D.M. Hohenhaus, G.M. Kelly, N.A. Kamal, P. Gupta, and L.I. Labzin et al. Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages J Biol Chem 288 2013 25362 25374
123. S. Song, S.W. Kang, and C. Choi Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1 Cardiovasc Res 85 2010 241 249
124. D.B. Sparrow, E.A. Miska, E. Langley, S. Reynaud-Deonauth, S. Kotecha, and N. Towers et al. MEF-2 function is modified by a novel co-repressor, MITR EMBO J 18 1999 5085 5098
125. V. Stambolic, and J.R. Woodgett Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation Biochem J 303 Pt 3 1994 701 704
126. B.E. Strauer, M. Brehm, T. Zeus, M. Kostering, A. Hernandez, and R.V. Sorg et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
127. C.C. Sucharov, S. Langer, M. Bristow, and L. Leinwand Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A Am J Physiol Cell Physiol 291 2006 C1029 C1037
128. X. Sun, L. Wei, Q. Chen, and R.M. Terek HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity J Biol Chem 284 2009 21881 21890
129. I.K. Sundar, H. Yao, and I. Rahman Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases Antioxid Redox Signal 18 2013 1956 1971
130. T. Takaya, T. Kawamura, T. Morimoto, K. Ono, T. Kita, and A. Shimatsu et al. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes J Biol Chem 283 2008 9828 9835
131. J. Taunton, C.A. Hassig, and S.L. Schreiber A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p Science 272 1996 408 411
132. F. Thaler Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications Pharm Pat Anal 1 2012 75 90
133. C.M. Trivedi, M.M. Lu, Q. Wang, and J.A. Epstein Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy J Biol Chem 283 2008 26484 26489
134. C.M. Trivedi, Y. Luo, Z. Yin, M. Zhang, W. Zhu, and T. Wang et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity Nat Med 13 2007 324 331
135. C.M. Trivedi, W. Zhu, Q. Wang, C. Jia, H.J. Kee, and L. Li et al. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation Dev Cell 19 2010 450 459
136. S.C. Tsai, and E. Seto Regulation of histone deacetylase 2 by protein kinase CK2 J Biol Chem 277 2002 31826 31833
137. C. Urbich, L. Rossig, D. Kaluza, M. Potente, J.N. Boeckel, and A. Knau et al. HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells Blood 113 2009 5669 5679
138. T. Usui, M. Okada, W. Mizuno, M. Oda, N. Ide, and T. Morita et al. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats Am J Physiol Heart Circ Physiol 302 2012 H1894 H1904
139. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, and V. Falk et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
140. R.B. Vega, B.C. Harrison, E. Meadows, C.R. Roberts, P.J. Papst, and E.N. Olson et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 Mol Cell Biol 24 2004 8374 8385
141. A. Verdel, S. Curtet, M.P. Brocard, S. Rousseaux, C. Lemercier, and M. Yoshida et al. Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm Curr Biol 10 2000 747 749
142. A. Villar-Garea, and M. Esteller Histone deacetylase inhibitors: understanding a new wave of anticancer agents Int J Cancer 112 2004 171 178
143. M.S. Walters, A. Erazo, P.R. Kinchington, and S. Silverstein Histone deacetylases 1 and 2 are phosphorylated at novel sites during varicella-zoster virus infection J Virol 83 2009 11502 11513
144. W. Wang, C.H. Ha, B.S. Jhun, C. Wong, M.K. Jain, and Z.G. Jin Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS Blood 115 2010 2971 2979
145. Z. Wang, L.K. Tsai, J. Munasinghe, Y. Leng, E.B. Fessler, and F. Chibane et al. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke Stroke 43 2012 2430 2436
146. K. Watamoto, M. Towatari, Y. Ozawa, Y. Miyata, M. Okamoto, and A. Abe et al. Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation Oncogene 22 2003 9176 9184
147. A.J. Watt, M.A. Battle, J. Li, and S.A. Duncan GATA4 is essential for formation of the proepicardium and regulates cardiogenesis Proc Natl Acad Sci U S A 101 2004 12573 12578
148. J. Wysocka, M.P. Myers, C.D. Laherty, R.N. Eisenman, and W. Herr Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1 Genes Dev 17 2003 896 911
149. W.S. Xu, R.B. Parmigiani, and P.A. Marks Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 26 2007 5541 5552
150. X.J. Yang, and E. Seto The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men Nat Rev Mol Cell Biol 9 2008 206 218
151. T. Yoshida, K.H. Kaestner, and G.K. Owens Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury Circ Res 102 2008 1548 1557
152. A. Zampetaki, L. Zeng, A. Margariti, Q. Xiao, H. Li, and Z. Zhang et al. Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow Circulation 121 2010 132 142
153. L. Zhang, B. Chen, Y. Zhao, P.M. Dubielecka, L. Wei, and G.J. Qin et al. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts J Biol Chem 287 2012 39338 39348
154. C.L. Zhang, T.A. McKinsey, S. Chang, C.L. Antos, J.A. Hill, and E.N. Olson Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy Cell 110 2002 479 488
155. L. Zhang, X. Qin, Y. Zhao, L. Fast, S. Zhuang, and P. Liu et al. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis J Pharmacol Exp Ther 341 2012 285 293
156. T.C. Zhao, G. Cheng, L.X. Zhang, Y.T. Tseng, and J.F. Padbury Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury Cardiovasc Res 76 2007 473 481
157. W. Zhu, C.M. Trivedi, D. Zhou, L. Yuan, M.M. Lu, and J.A. Epstein Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness Circ Res 105 2009 1240 1247